[go: up one dir, main page]

WO2002032946A8 - Nouveaux composes - Google Patents

Nouveaux composes

Info

Publication number
WO2002032946A8
WO2002032946A8 PCT/EP2001/011983 EP0111983W WO0232946A8 WO 2002032946 A8 WO2002032946 A8 WO 2002032946A8 EP 0111983 W EP0111983 W EP 0111983W WO 0232946 A8 WO0232946 A8 WO 0232946A8
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
basb207
haemophilus influenzae
polynucleotides
nontypeable haemophilus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/011983
Other languages
English (en)
Other versions
WO2002032946A2 (fr
WO2002032946A3 (fr
Inventor
Joelle Thonnard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to EP01987767A priority Critical patent/EP1328541A2/fr
Priority to CA002426413A priority patent/CA2426413A1/fr
Priority to AU2002220635A priority patent/AU2002220635A1/en
Publication of WO2002032946A2 publication Critical patent/WO2002032946A2/fr
Publication of WO2002032946A3 publication Critical patent/WO2002032946A3/fr
Publication of WO2002032946A8 publication Critical patent/WO2002032946A8/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des polypeptides BASB207, des polynucléotides codant les polypeptides BASB207, et des procédés de fabrication de tels polypeptides au moyen de techniques de recombinaison. L'invention concerne également les utilisations diagnostiques, prophylactiques, et thérapeutiques desdits polypeptides.
PCT/EP2001/011983 2000-10-17 2001-10-16 Nouveaux composes Ceased WO2002032946A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP01987767A EP1328541A2 (fr) 2000-10-17 2001-10-16 Basb207 polypeptides et polynucleotides de haemophilus influenzae non typable
CA002426413A CA2426413A1 (fr) 2000-10-17 2001-10-16 Nouveaux composes
AU2002220635A AU2002220635A1 (en) 2000-10-17 2001-10-16 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0025488.8A GB0025488D0 (en) 2000-10-17 2000-10-17 Novel compounds
GB0025488.8 2000-10-17

Publications (3)

Publication Number Publication Date
WO2002032946A2 WO2002032946A2 (fr) 2002-04-25
WO2002032946A3 WO2002032946A3 (fr) 2002-10-31
WO2002032946A8 true WO2002032946A8 (fr) 2003-01-09

Family

ID=9901500

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/011983 Ceased WO2002032946A2 (fr) 2000-10-17 2001-10-16 Nouveaux composes

Country Status (5)

Country Link
EP (1) EP1328541A2 (fr)
AU (1) AU2002220635A1 (fr)
CA (1) CA2426413A1 (fr)
GB (1) GB0025488D0 (fr)
WO (1) WO2002032946A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004009621A2 (fr) * 2002-07-24 2004-01-29 Id Biomedical Corporation Polypeptides d'haemophilus influenzae inclassable

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5552396A (en) * 1995-04-21 1996-11-07 Human Genome Sciences, Inc. Nucleotide sequence of the haemophilus influenzae rd genome, fragments thereof, and uses thereof

Also Published As

Publication number Publication date
WO2002032946A2 (fr) 2002-04-25
CA2426413A1 (fr) 2002-04-25
AU2002220635A1 (en) 2002-04-29
EP1328541A2 (fr) 2003-07-23
WO2002032946A3 (fr) 2002-10-31
GB0025488D0 (en) 2000-11-29

Similar Documents

Publication Publication Date Title
WO1999058562A3 (fr) Nouveaux composes
WO1999055873A3 (fr) Polynucleotide(s) et polypeptides basb006 isoles a partir de neisseria meningites
WO1999061620A3 (fr) polypeptides antigéniques neisseria meningitidis, polynucléotides correspondants et anticorps protecteurs
WO2000055327A3 (fr) Nouveaux composes
WO2002034768A3 (fr) Nouveaux composes
WO2002032946A3 (fr) Nouveaux composes
WO2002088361A3 (fr) Nouveaux composes
WO2000043519A3 (fr) Polypeptides neisseria meningitidis
WO1999064602A3 (fr) Polynucleotides et polypeptides de $i(branhamella catarrhalis)
WO2002030971A3 (fr) Nouveaux composes
WO2002024729A3 (fr) Nouveaux composés
WO2003055905A3 (fr) Nouveaux composes
WO2002030960A3 (fr) Nouveaux composes
WO2002034778A3 (fr) Nouveaux composes
HK1047943A1 (zh) 黏膜炎莫拉氏菌basb114抗原及其用途
WO2002100891A3 (fr) Nouveaux composes
WO2002079237A3 (fr) Nouveaux composes
WO2000042191A3 (fr) Nouveaux composes
WO2000071724A3 (fr) Composes nouveaux
WO2001009332A3 (fr) Nouveaux composes
WO2002088360A3 (fr) Nouveaux composes
WO2002066503A3 (fr) Nouveaux composes
WO2002032945A3 (fr) Nouveaux composes
WO2002034772A3 (fr) Nouveaux composes
WO2002060938A3 (fr) Nouveaux composes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page

Free format text: UNDER (57) PUBLISHED ABSTRACT REPLACED BY CORRECT ABSTRACT

WWE Wipo information: entry into national phase

Ref document number: 2426413

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001987767

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001987767

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001987767

Country of ref document: EP